… highly skilled in evaluating patients and managing clinical issues and adverse events that commonly arise during the procedure, particularly in patients with comorbid anemia, renal failure, cardiovascular disease, serum protein abnormalities or other risk factors. [ 25 ] Their k…

…d all other beneficiaries receiving Part B coverage of ustekinumab before these events occurred. The Center is also concerned that CMS’s current policies for determining when a drug is “usually self-administered by the patient,” and subsequent non-coverage of drugs that were prev…